Jyoti CNC Q1FY27: consolidated PAT falls 20% YoY as French subsidiary losses hit margins

Jyoti CNC's Q1FY27 (quarter ended June 30, 2026) consolidated print was mixed: revenue rose 23.97% YoY to ₹508.47 Cr (₹410.17 Cr a year ago) but PAT fell 19.99% YoY to ₹57.14 Cr (₹71.42 Cr) — profit declining even as the top line grew. Sequentially both metrics eased from a stronger Q4FY26 (revenue -15.13% QoQ from ₹599.16 Cr, PAT -36.92% QoQ from ₹90.57 Cr), consistent with a seasonally softer Q1 for an order-book-driven capital-goods business. Consolidated EPS was ₹2.51 versus ₹3.14 a year ago. No reliable street estimates specific to this quarter's print could be sourced, so the actual cannot be benchmarked against consensus (vsStreet: unknown). The YoY profit decline sits entirely on the margin line, not on any exceptional item — both periods show nil exceptional/extraordinary items. Consolidated NPM compressed to 11.24% from 16.58% a year ago, and OPM (EBITDA margin) fell to 21.40% from 24.43%, both now below management's own guided 25-27% EBITDA margin band for FY27/FY28 laid out on the Q3FY26 concall. The compression traces to the group's overseas operations: per the auditor's review note, subsidiaries and step-down subsidiaries (including the French Huron entities) posted a combined net loss of ₹30.07 Cr on just ₹32.21 Cr of revenue this quarter. That overseas drag is the entire story behind the standalone-vs-consolidated gap — standalone (parent-only) PAT was ₹87.47 Cr, up 21.28% YoY, with EPS of ₹3.85, more than 50% higher than the consolidated EPS. The overseas drag is not new: step-down subsidiary Huron Graffenstaden SAS (France) remains under an ongoing French judicial investigation into alleged dual-use export-control violations, with interim seizure of €3.02 million in funds and two Jyoti SAS-owned residential properties, and restrictions on the entity's Director General — unchanged from prior disclosures. Standalone financials also carry a management note that no impairment has been taken on the investment in this loss-making subsidiary chain, on the view that recovery is likely and the investment remains strategic — auditors did not qualify this but it is a judgment call worth tracking. On revenue, consolidated growth of 23.97% YoY trails the lower end of management's guided 25-30% FY27 band (given alongside confidence in tripling India capacity by September 2026); the quarter is a narrow miss on revenue guidance and a more pronounced miss on the margin guidance. No company press release accompanied this filing beyond the procedural board-outcome letter, so management's own framing of the quarter's drivers is not yet available — the filing is limited to the statutory result and auditor review reports. Watch whether the India capacity expansion and progress on the Huron investigation feed through to margin recovery toward the guided 25-27% band over the rest of FY27.